+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mannkind Corporation - logo

MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.

Pharmaceutical Excipients Market - Forecast (2020 - 2025) - Product Thumbnail Image

Pharmaceutical Excipients Market - Forecast (2020 - 2025)

  • Report
  • March 2020
  • 109 Pages
  • Global
From
Anaphylaxis - Pipeline Review, H2 2020 - Product Thumbnail Image

Anaphylaxis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
North America Drug Delivery Systems Market to 2027 - Regional Analysis and Forecasts by Route of Administration; Distribution Channel; and Application, and Country - Product Thumbnail Image

North America Drug Delivery Systems Market to 2027 - Regional Analysis and Forecasts by Route of Administration; Distribution Channel; and Application, and Country

  • Report
  • June 2019
  • 249 Pages
  • North America
From
Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration; Distribution Channel; Application and Geography - Product Thumbnail Image

Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration; Distribution Channel; Application and Geography

  • Report
  • May 2019
  • 343 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • December 2020
  • 314 Pages
  • Global
From
Needle-Free Diabetes Care Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Needle-Free Diabetes Care Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 81 Pages
  • Global
From
Acute Lymphocytic Leukemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Acute Lymphocytic Leukemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1809 Pages
  • Global
From
PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition - Product Thumbnail Image

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

  • Report
  • December 2018
  • 74 Pages
  • Global
From
Inhalers - Medical Devices Pipeline Assessment, 2019 - Product Thumbnail Image

Inhalers - Medical Devices Pipeline Assessment, 2019

  • Report
  • May 2019
  • 357 Pages
  • Global
From
Cystic Fibrosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 550 Pages
  • Global
From
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 667 Pages
  • Global
From
Nontuberculous Mycobacteria (Ntm) Infections - Pipeline Insight, 2021 - Product Thumbnail Image

Nontuberculous Mycobacteria (Ntm) Infections - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 60 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
MannKind Corporation (MNKD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

MannKind Corporation (MNKD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
MannKind Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

MannKind Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Comprehensive Report on MannKind Corporation, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on MannKind Corporation, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2023
  • 51 Pages
From
Loading Indicator